ArticleOncotarget2020
Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells.
Rachael A Clark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleOncotarget2020
Rachael A Clark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.